We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $100M
This Fund
S&P 500
This Quarter Est. Return
+4.14%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$100M
AUM Growth
-$34.3M
Cap. Flow
-$33.3M
Cap. Flow %
-33.2%
Top 10 Hldgs %
26.12%
Holding
294
New
64
Increased
32
Reduced
107
Closed
85

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$5.08M
2
UNH icon
UnitedHealth
UNH
+$4.05M
3
JNJ icon
Johnson & Johnson
JNJ
+$2.82M
4
NVO
Novo Nordisk
NVO
+$2.52M
5
ABBV icon
AbbVie
ABBV
+$2.39M

Top Sells

Rank Stock Value
1
RITM icon
Rithm Capital
RITM
+$4.32M
2
HRMY icon
Harmony Biosciences
HRMY
+$3.88M
3
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$3.12M
4
EFC
Ellington Financial
EFC
+$2.6M
5
MTG icon
MGIC Investment
MTG
+$2.54M

Sector Composition

Rank Sector Weight
1 Healthcare 54.58%
2 Real Estate 7.4%
3 Industrials 5.96%
4 Financials 5.87%
5 Technology 4.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHYG icon
101
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.61B
$254K 0.25%
5,963
+380
+7% +$16.3K
HYGV icon
102
FlexShares High Yield Value-Scored Bond Index Fund
HYGV
$1.1B
$253K 0.25%
6,224
+397
+7% +$16.3K
JNK icon
103
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.36B
$253K 0.25%
2,650
+168
+7% +$16.2K
GHYG icon
104
iShares US & Intl High Yield Corp Bond ETF
GHYG
$185M
$253K 0.25%
5,736
+424
+8% +$19K
FALN icon
105
iShares Fallen Angels USD Bond ETF
FALN
$1.64B
$252K 0.25%
9,443
+586
+7% +$15.8K
ALDX icon
106
Aldeyra Therapeutics
ALDX
$102M
$234K 0.23%
+46,913
New +$241K
KRYS icon
107
Krystal Biotech
KRYS
$10.5B
$231K 0.23%
+1,474
New +$261K
COR icon
108
Cencora
COR
$59.9B
$221K 0.22%
+982
New +$231K
EG icon
109
Everest Group
EG
$15.1B
$214K 0.21%
590
-46
-7% -$17.2K
V icon
110
Visa
V
$682B
$212K 0.21%
671
-19
-3% -$5.71K
TMUS icon
111
T-Mobile US
TMUS
$208B
$207K 0.21%
939
-25
-3% -$5.69K
KGC icon
112
Kinross Gold
KGC
$27B
$207K 0.21%
22,336
-3,845
-15% -$37.9K
CPRT icon
113
Copart
CPRT
$25.6B
$206K 0.21%
3,596
-106
-3% -$6.04K
AIZ icon
114
Assurant
AIZ
$13.7B
$205K 0.2%
963
-54
-5% -$11.2K
BR icon
115
Broadridge
BR
$17.3B
$204K 0.2%
904
-24
-3% -$5.38K
RCL icon
116
Royal Caribbean
RCL
$77B
$202K 0.2%
877
-152
-15% -$33.7K
AJG icon
117
Arthur J. Gallagher & Co
AJG
$65.2B
$202K 0.2%
711
-20
-3% -$5.82K
AGIO icon
118
Agios Pharmaceuticals
AGIO
$2.36B
$202K 0.2%
+6,140
New +$288K
DVA icon
119
DaVita
DVA
$15.2B
$198K 0.2%
1,323
-73
-5% -$11.4K
CME icon
120
CME Group
CME
$88.5B
$194K 0.19%
837
-20
-2% -$4.6K
BRO icon
121
Brown & Brown
BRO
$23.5B
$190K 0.19%
1,863
-54
-3% -$5.77K
TJX icon
122
TJX Companies
TJX
$171B
$190K 0.19%
1,571
-43
-3% -$5.13K
CBOE icon
123
Cboe Global Markets
CBOE
$28.6B
$188K 0.19%
963
-26
-3% -$5.35K
REM icon
124
iShares Mortgage Real Estate ETF
REM
$559M
$185K 0.19%
8,685
-6,241
-42% -$142K
PR
125
Permian Resources
PR
$16.9B
$185K 0.18%
12,857
-2,109
-14% -$30.6K
3 4
5
6 7

Similar funds

WCM
Weber Capital Management San Francisco, California $100M AUM
FCM
Fourier Capital Management Hong Kong $100M AUM
BIA
Baer Investment Advisory Corte Madera, California $100M AUM 23.87% 1-Year Est. Return
AGAM
Audent Global Asset Management West Hollywood, California $100M AUM 22.83% 1-Year Est. Return
E
Entelevest Coral Gables, Florida $100M AUM
HCM
Hicks Capital Management Columbus, Ohio $100M AUM 14.29% 1-Year Est. Return
AC
Arrow Capital Sydney, Australia $100M AUM 68.52% 1-Year Est. Return
OIS
OneAscent Investment Solutions Birmingham, Alabama $100M AUM 15.97% 1-Year Est. Return

AlphaCentric Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, AlphaCentric Advisors held 294 positions worth $100M, down 25% from $135M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

AlphaCentric Advisors withdrew a net $33.3M in Q4 2024, closing 85 positions and reducing 107 holdings. Its most notable exit was Rithm Capital, an estimated $4.32M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, down from 58% a quarter earlier, followed by Real Estate and Industrials.

Against the trend, AlphaCentric Advisors opened a new position in Eli Lilly worth $4.74M.

  • AlphaCentric Advisors's largest Q4 2024 buy was Eli Lilly: 6,140 shares worth $4.74M.
  • AlphaCentric Advisors added most to iShares 1-3 Year Treasury Bond ETF in Q4 2024, an estimated $2.03M increase.
  • AlphaCentric Advisors's biggest Q4 2024 reduction was Neurocrine Biosciences, cutting an estimated $2.33M.
  • AlphaCentric Advisors fully exited Rithm Capital in Q4 2024, selling an estimated $4.32M.
  • AlphaCentric Advisors's ten largest holdings make up 26% of its $100M portfolio in Q4 2024.
  • AlphaCentric Advisors opened 64 new positions and closed 85 in Q4 2024.
  • AlphaCentric Advisors's portfolio value fell 25% quarter-over-quarter to $100M.

Based on AlphaCentric Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.